InVivo Therapeutics Holdings Price Prediction

NVIVDelisted Stock  USD 0.32  0.09  21.95%   
At this time, the value of RSI of InVivo Therapeutics' share price is approaching 40. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling InVivo Therapeutics, making its price go up or down.

Oversold Vs Overbought

40

 
Oversold
 
Overbought
InVivo Therapeutics stock price prediction is an act of determining the future value of InVivo Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of InVivo Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of InVivo Therapeutics and does not consider all of the tangible or intangible factors available from InVivo Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with InVivo Therapeutics Holdings, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether delisted stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of InVivo Therapeutics based on different types of headlines from major news networks to social media. The InVivo stock price prediction module provides an analysis of price elasticity to changes in media outlook on InVivo Therapeutics over a specific investment horizon. Using InVivo Therapeutics hype-based prediction, you can estimate the value of InVivo Therapeutics Holdings from the perspective of InVivo Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in InVivo Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in InVivo Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying InVivo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

InVivo Therapeutics after-hype prediction price

    
  USD 0.39  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of InVivo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.020.3045.97
Details
Naive
Forecast
LowNextHigh
0.010.3846.05
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.210.460.72
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as InVivo Therapeutics. Your research has to be compared to or analyzed against InVivo Therapeutics' peers to derive any actionable benefits. When done correctly, InVivo Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in InVivo Therapeutics.

InVivo Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of InVivo Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in InVivo Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of InVivo Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

InVivo Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting InVivo Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on InVivo Therapeutics' historical news coverage. InVivo Therapeutics' after-hype downside and upside margins for the prediction period are 0.02 and 46.06, respectively. We have considered InVivo Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.32
0.39
After-hype Price
46.06
Upside
InVivo Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of InVivo Therapeutics is based on 3 months time horizon.

InVivo Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as InVivo Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading InVivo Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with InVivo Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.96 
45.67
  0.07 
  0.07 
7 Events / Month
13 Events / Month
In about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.32
0.39
21.88 
65,243  
Notes

InVivo Therapeutics Hype Timeline

InVivo Therapeutics is now traded for 0.32. The entity has historical hype elasticity of 0.07, and average elasticity to hype of competition of -0.07. InVivo is forecasted to increase in value after the next headline, with the price projected to jump to 0.39 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 21.88%, whereas the daily expected return is now at 0.96%. The volatility of related hype on InVivo Therapeutics is about 65689.73%, with the expected price after the next announcement by competition of 0.25. The company currently holds 949 K in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. InVivo Therapeutics has a current ratio of 5.53, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist InVivo Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, InVivo Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like InVivo Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for InVivo to invest in growth at high rates of return. When we think about InVivo Therapeutics' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 7 days.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

InVivo Therapeutics Related Hype Analysis

Having access to credible news sources related to InVivo Therapeutics' direct competition is more important than ever and may enhance your ability to predict InVivo Therapeutics' future price movements. Getting to know how InVivo Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how InVivo Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
VRAXVirax Biolabs Group 0.04 1 per month 0.00 (0.14) 6.15 (7.04) 27.96 
BWVBWV 0.02 7 per month 0.00 (0.24) 9.09 (12.20) 42.42 
REVBRevelation Biosciences(0.10)10 per month 0.00 (0.13) 13.33 (18.75) 95.47 
HILSHillstream Biopharma(0.01)2 per month 0.00 (0.14) 7.89 (8.33) 24.20 
KPRXKiora Pharmaceuticals(0.03)6 per month 5.31  0.04  14.52 (9.09) 72.05 
NXTCNextCure 0.15 4 per month 4.85  0.09  8.13 (7.93) 32.17 
CTMXCytomX Therapeutics(0.10)10 per month 3.82  0.02  8.16 (5.80) 50.71 
NLTXNeoleukin Therapeutics(0.12)2 per month 0.00 (0.04) 6.67 (5.67) 15.97 
SPROSpero Therapeutics 0.08 9 per month 3.29  0  4.82 (5.59) 16.20 
ASMBAssembly Biosciences(1.88)7 per month 3.30  0.10  6.20 (4.63) 19.82 
NTRBNutriband 0.35 5 per month 4.40  0.08  9.76 (7.53) 44.56 
QNRXQuoin Pharmaceuticals Ltd(0.27)8 per month 0.00 (0.34) 4.69 (9.67) 53.64 
LGVNLongeveron LLC(0.15)8 per month 0.00 (0.15) 8.37 (18.80) 114.17 
RNXTRenovoRx 0.04 7 per month 5.56  0.04  12.78 (7.78) 42.62 
ANEBAnebulo Pharmaceuticals(0.05)5 per month 3.50  0.04  6.20 (5.51) 20.75 
RZLTRezolute 0.14 9 per month 5.25  0.27  12.17 (7.29) 21.05 
HCWBHCW Biologics(0.01)4 per month 2.89  0.12  8.50 (5.08) 24.78 
ELYMEliem Therapeutics(0.12)7 per month 3.04  0.07  4.17 (6.23) 79.43 
MOLNMolecular Partners AG(0.08)5 per month 0.00 (0.07) 5.67 (7.14) 26.69 
SNTISenti Biosciences(0.01)2 per month 0.00 (0.08) 7.50 (8.70) 26.47 
SABSSAB Biotherapeutics 0.65 9 per month 0.00 (0.09) 6.74 (8.00) 27.62 

InVivo Therapeutics Additional Predictive Modules

Most predictive techniques to examine InVivo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for InVivo using various technical indicators. When you analyze InVivo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About InVivo Therapeutics Predictive Indicators

The successful prediction of InVivo Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as InVivo Therapeutics Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of InVivo Therapeutics based on analysis of InVivo Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to InVivo Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to InVivo Therapeutics's related companies.

Story Coverage note for InVivo Therapeutics

The number of cover stories for InVivo Therapeutics depends on current market conditions and InVivo Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that InVivo Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about InVivo Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

InVivo Therapeutics Short Properties

InVivo Therapeutics' future price predictability will typically decrease when InVivo Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of InVivo Therapeutics Holdings often depends not only on the future outlook of the potential InVivo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. InVivo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.5 M
Cash And Short Term Investments16.4 M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in InVivo Stock

If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Volatility Analysis
Get historical volatility and risk analysis based on latest market data